PrimeRFP SCOUT · Federal Contract Recompete Brief

VA25817J0061Chemistry covid19 IGG reagents — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. Competition previously drew 2 offers. PoP ended Sep 30, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Sep 30, 2021
PoP end
$-739,207.22
Obligated
$6.8M
Potential
334516
NAICS
6550
PSC
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract numberVA25817J0061
Also listed asVA258-17-J-0061
Also listed asV797D60637-VA25817J0061
Agency262-Network Contract Office 22 (36C262)
Awarding office262-Network Contract Office 22 (36C262)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDVV797D60637
Place of performanceALBUQUERQUE NM
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationVA258-16-Q-1011
PoP startOct 6, 2016
PoP end (current)Sep 30, 2021
Obligated$-739,207.22
Current value$6.8M
Potential value$6.8M

CHEMISTRY COVID19 IGG REAGENTS is a federal award for 262-Network Contract Office 22 (36C262) held by Ortho-Clinical Diagnostics, Inc. Estimated value $6.8M ($-739,207.22 obligated). Current period of performance ends Sep 30, 2021. Last award drew 2 bidders. Place of performance: ALBUQUERQUE NM. Related solicitation VA258-16-Q-1011.

Recompete timing

Public
● Past PoP end (1827 days ago)

Current PoP ended Sep 30, 2021 (1827 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on VA25817J0061? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile →

Related awards

Same parent · incumbent
W91YTZ22P0056
CHEMISTRY ANALYZERS AND REAGENTS
$813K
Sep 30, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026
36C26225N1061
BLOOD BANK AUTOMATION CPT SOLUTION
$493K
Sep 29, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract VA25817J0061?

VA25817J0061 (Chemistry covid19 IGG reagents) is a 262-Network Contract Office 22 (36C262) award with a potential value of $6.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is VA258-17-J-0061?

VA258-17-J-0061 is the dashed form of PIID VA25817J0061 (Chemistry covid19 IGG reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded VA25817J0061?

262-Network Contract Office 22 (36C262) awarded VA25817J0061 to Ortho-Clinical Diagnostics, Inc (potential $6.8M).

Who is the incumbent on VA25817J0061?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2021.

When does Ortho-Clinical Diagnostics, Inc’s VA25817J0061 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on VA25817J0061? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/VA25817J0061